Algemeen Ziekenhuis St Jan Brugge

Bruges 8000

0 studies enrolling now · 3 studies all time

What they study most

Metastatic Breast Cancer, Migraine

Studies at this site

• A Study of Lasmiditan (LY573144) Over Four Migraine Attacks — Completed
• A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine — Completed
• A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer — Withdrawn before enrolling